NAUT:NASDAQNautilus Biotechnology, Inc. Analysis
Data as of 2026-08-19 - not real-time
$0.85
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $0.8518, Nautilus Biotechnology, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Over a rolling month the price has lost 49.6%. Momentum indicators put RSI at 21.6 (oversold) with MACD reading bullish. Recent trading has carved out support near $0.8410 and resistance around $1.79.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 369.6% above the current quote.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 113.2%, a beta of 0.06 and a maximum drawdown of 78.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 369.6% above the current quote.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 113.2%, a beta of 0.06 and a maximum drawdown of 78.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
SEATTLE, July 28, 2026 GLOBE NEWSWIRE -- Nautilus Biotechnology, Inc.Nautilus Biotechnology Inc NAUT leverages proteoform advancements and strategic collaborations to drive future growth...Seeking Alpha21dNautilus Biotechnology, Inc.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 21.6 signals oversold conditions
- Trading below the 200-day average of 2.21
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 21.6 signals oversold conditions
- Trading below the 200-day average of 2.21
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +369.6% versus the current price
- Negative return on equity of -36.2%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-1.2
ROE-36.21%
ROA-20.83%
Debt/Equity21.21
P/B Ratio0.8
Op. Cash Flow$-50235000
Free Cash Flow$-29418376
Industry P/E30.3
Technical Analysis
TrendBearish
RSI21.6
Support$0.84
Resistance$1.79
MA 20$1.10
MA 50$1.64
MA 200$2.21
MACDBullish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Target Price$4.00
Upside/Downside369.59%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.06
Volatility113.21%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.